Related Experiment Video
Updated: Feb 8, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Decreased tumorigenicity in vivo when transforming growth factor beta treatment causes cancer cell senescence
Yoshinori Katakura1, Eriko Nakata, Yukiko Tabira
1Department of Genetic Resources Technology, Faculty of Agriculture, Kyushu University, Fukuoka 812-8581, Japan. katakura@grt.kyushu-u.ac.jp
Abstract:
We have previously reported that transforming growth factor beta (TGF-beta) triggers two independent senescence programs, 1) replicative senescence dependent upon telomere shortening and 2) premature senescence independent of telomere shortening, in the cell line of A549 human lung adenocarcinoma. In this study, we examined the possibility that cancer cell tumor phenotypes could be suppressed by forced senescence. We used A549 cells treated with TGF-beta for a long time (over 50 days), where senescence was induced in a telomere-shortening-dependent or an independent way. Fully senescent A549 cells were elongated, acquired contact inhibition capabilities when reaching confluence, and secreted the senescence-associated cytokine IL-6. Furthermore, senescent A549 cells had no tumorigenicity in nude mice. These results indicate that the forced induction of senescence in cancer cells may be a novel and potentially powerful method for advancing anti-cancer therapy.
Insights
Forced senescence in A549 lung adenocarcinoma cells suppressed tumor formation. This study shows inducing senescence may be a new anti-cancer therapy strategy.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Transforming growth factor beta (TGF-beta) induces two senescence pathways in A549 lung adenocarcinoma cells: replicative and premature.
- Senescence is a cellular state of irreversible growth arrest.
Purpose of the Study:
- To investigate if forced senescence can suppress cancer cell tumor phenotypes.
- To evaluate the tumorigenicity of senescent A549 cells.
Main Methods:
- A549 human lung adenocarcinoma cells were treated with TGF-beta for over 50 days to induce senescence.
- Senescence was induced via telomere shortening-dependent or independent pathways.
- Senescent cells were analyzed for morphology, contact inhibition, cytokine secretion (IL-6), and tumorigenicity in nude mice.
Main Results:
- Long-term TGF-beta treatment induced senescence in A549 cells.
- Senescent A549 cells exhibited altered morphology, contact inhibition, and secreted IL-6.
- Crucially, senescent A549 cells demonstrated a complete lack of tumorigenicity in vivo.
Conclusions:
- Forced induction of senescence effectively suppresses the tumor-forming capabilities of cancer cells.
- Targeting senescence pathways presents a promising novel strategy for developing advanced anti-cancer therapies.
Related Concept Videos
Decreasing Function
Factors Influencing Microbial Growth: pH
Replicative Cell Senescence
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Treatment Resistant Cancers
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...

